Home › Companies › HAEMONETICS CORP. › 2024-2025
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and HAEMONETICS CORP.’s Form 8-K, filed July 25, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of July 25, 2024: 11 items on HAEMONETICS CORP.’s Form 8-K, filed July 25, 2024: 2 approved · 9 passed (calculated).
No notable dissent.
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore HAEMONETICS CORP. in the interactive database Compare manager voting policies
These tallies are HAEMONETICS CORP.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed July 25, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Christopher A. Simon | 47,563,311 | -- | -- | 269,386 | 1,079,553 | 99.4% | Passed (calculated) | — |
| Elect Director: Robert E. Abernathy | 47,233,098 | -- | -- | 599,599 | 1,079,553 | 99% | Passed (calculated) | — |
| Elect Director: Diane M. Bryant | 47,637,507 | -- | -- | 195,190 | 1,079,553 | 99.6% | Passed (calculated) | — |
| Elect Director: Michael J. Coyle | 47,492,931 | -- | -- | 339,766 | 1,079,553 | 99.3% | Passed (calculated) | — |
| Elect Director: Charles J. Dockendorff | 46,789,643 | -- | -- | 1,043,054 | 1,079,553 | 98% | Passed (calculated) | — |
| Elect Director: Lloyd E. Johnson | 47,243,880 | -- | -- | 588,817 | 1,079,553 | 99% | Passed (calculated) | — |
| Elect Director: Mark W. Kroll | 46,938,807 | -- | -- | 893,890 | 1,079,553 | 98% | Passed (calculated) | — |
| Elect Director: Claire Pomeroy | 47,553,094 | -- | -- | 279,603 | 1,079,553 | 99.4% | Passed (calculated) | — |
| Elect Director: Ellen M. Zane | 47,122,780 | -- | -- | 709,917 | 1,079,553 | 99% | Passed (calculated) | — |
| 2. The compensation of the Company's named executive officers | 46,230,466 | 1,460,004 | 142,227 | -- | 1,079,553 | 97% | Approved | — |
| 3. The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending March 30, 2024 | 47,738,769 | 1,049,682 | 123,799 | -- | -- | 98% | Approved | — |
Source: HAEMONETICS CORP., Form 8-K, filed with the SEC on July 25, 2024 — read the filing on EDGAR.
See voting trends for Health Care companies, 2024-2025: shareholder support by sector and by company size.
352 asset managers disclosed a vote on at least one HAEMONETICS CORP. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 3 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Prior year: 96.3% for (August 4, 2023 meeting) ▲ 1.5 pts
Description as filed by funds: Election of Directors: Charles J. Dockendorff
HAEMONETICS CORP.’s own tally for this item (“Elect Director: Charles J. Dockendorff”): 46,789,643 for, 1,043,054 withheld, per its Form 8-K filed July 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 114 asset managers below reported 31,295,701 for, 100,978 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,196,351 | 0 | 0 | 0 | For |
| Capital Group | 3,681,875 | 0 | 0 | 0 | For |
| BlackRock | 3,247,069 | 0 | 0 | 0 | For |
| AMCAP FUND | 3,053,480 | 0 | 0 | 0 | For |
| Neuberger Berman | 2,265,105 | 0 | 0 | 0 | For |
| Fidelity | 1,277,981 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,206,185 | 0 | 0 | 0 | For |
| Royce | 1,017,845 | 0 | 0 | 0 | For |
| Thrivent | 808,322 | 0 | 0 | 0 | For |
| Dimensional | 763,345 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 737,264 | 0 | 0 | 0 | For |
| Charles Schwab | 542,230 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 485,600 | 0 | 0 | 0 | For |
| State Street | 399,117 | 0 | 0 | 0 | For |
| Hartford | 397,743 | 0 | 0 | 0 | For |
| Allspring | 393,720 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 290,481 | 0 | 0 | 0 | For |
| Brighthouse | 284,890 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 275,060 | 0 | 0 | 0 | For |
| John Hancock | 234,550 | 0 | 0 | 0 | For |
| Equitable | 205,349 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 197,612 | 0 | 0 | 0 | For |
| HEARTLAND GROUP INC | 180,000 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 160,731 | 0 | 0 | 0 | For |
| SCHWARTZ INVESTMENT TRUST | 151,000 | 0 | 0 | 0 | For |
Showing the 25 largest of 114 asset managers. All 114 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.4% Majority: yes · of votes cast
Prior year: 99.3% for (August 4, 2023 meeting) ▲ 0.1 pts
Description as filed by funds: Election of Directors: Christopher A. Simon
HAEMONETICS CORP.’s own tally for this item (“Elect Director: Christopher A. Simon”): 47,563,311 for, 269,386 withheld, per its Form 8-K filed July 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 99.4% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 114 asset managers below reported 31,379,759 for, 16,920 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,196,351 | 0 | 0 | 0 | For |
| Capital Group | 3,681,875 | 0 | 0 | 0 | For |
| BlackRock | 3,247,069 | 0 | 0 | 0 | For |
| AMCAP FUND | 3,053,480 | 0 | 0 | 0 | For |
| Neuberger Berman | 2,265,105 | 0 | 0 | 0 | For |
| Fidelity | 1,277,981 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,206,185 | 0 | 0 | 0 | For |
| Royce | 1,017,845 | 0 | 0 | 0 | For |
| Thrivent | 808,322 | 0 | 0 | 0 | For |
| Dimensional | 763,345 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 737,264 | 0 | 0 | 0 | For |
| Charles Schwab | 542,230 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 485,600 | 0 | 0 | 0 | For |
| State Street | 399,117 | 0 | 0 | 0 | For |
| Hartford | 397,743 | 0 | 0 | 0 | For |
| Allspring | 393,720 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 290,481 | 0 | 0 | 0 | For |
| Brighthouse | 284,890 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 275,060 | 0 | 0 | 0 | For |
| John Hancock | 234,550 | 0 | 0 | 0 | For |
| Equitable | 205,349 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 197,612 | 0 | 0 | 0 | For |
| HEARTLAND GROUP INC | 180,000 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 160,731 | 0 | 0 | 0 | For |
| SCHWARTZ INVESTMENT TRUST | 151,000 | 0 | 0 | 0 | For |
Showing the 25 largest of 114 asset managers. All 114 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.4% Majority: yes · of votes cast
Prior year: 99.2% for (August 4, 2023 meeting) ▲ 0.2 pts
Description as filed by funds: Election of Directors: Claire Pomeroy
HAEMONETICS CORP.’s own tally for this item (“Elect Director: Claire Pomeroy”): 47,553,094 for, 279,603 withheld, per its Form 8-K filed July 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 99.4% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 114 asset managers below reported 31,378,947 for, 17,732 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,196,351 | 0 | 0 | 0 | For |
| Capital Group | 3,681,875 | 0 | 0 | 0 | For |
| BlackRock | 3,247,069 | 0 | 0 | 0 | For |
| AMCAP FUND | 3,053,480 | 0 | 0 | 0 | For |
| Neuberger Berman | 2,265,105 | 0 | 0 | 0 | For |
| Fidelity | 1,277,981 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,206,185 | 0 | 0 | 0 | For |
| Royce | 1,017,845 | 0 | 0 | 0 | For |
| Thrivent | 808,322 | 0 | 0 | 0 | For |
| Dimensional | 763,345 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 737,264 | 0 | 0 | 0 | For |
| Charles Schwab | 542,230 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 485,600 | 0 | 0 | 0 | For |
| State Street | 399,117 | 0 | 0 | 0 | For |
| Hartford | 397,743 | 0 | 0 | 0 | For |
| Allspring | 393,720 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 290,481 | 0 | 0 | 0 | For |
| Brighthouse | 284,890 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 275,060 | 0 | 0 | 0 | For |
| John Hancock | 234,550 | 0 | 0 | 0 | For |
| Equitable | 205,349 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 197,612 | 0 | 0 | 0 | For |
| HEARTLAND GROUP INC | 180,000 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 160,731 | 0 | 0 | 0 | For |
| SCHWARTZ INVESTMENT TRUST | 151,000 | 0 | 0 | 0 | For |
Showing the 25 largest of 114 asset managers. All 114 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.6% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Diane M. Bryant
HAEMONETICS CORP.’s own tally for this item (“Elect Director: Diane M. Bryant”): 47,637,507 for, 195,190 withheld, per its Form 8-K filed July 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 99.6% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 114 asset managers below reported 31,378,947 for, 17,732 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,196,351 | 0 | 0 | 0 | For |
| Capital Group | 3,681,875 | 0 | 0 | 0 | For |
| BlackRock | 3,247,069 | 0 | 0 | 0 | For |
| AMCAP FUND | 3,053,480 | 0 | 0 | 0 | For |
| Neuberger Berman | 2,265,105 | 0 | 0 | 0 | For |
| Fidelity | 1,277,981 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,206,185 | 0 | 0 | 0 | For |
| Royce | 1,017,845 | 0 | 0 | 0 | For |
| Thrivent | 808,322 | 0 | 0 | 0 | For |
| Dimensional | 763,345 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 737,264 | 0 | 0 | 0 | For |
| Charles Schwab | 542,230 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 485,600 | 0 | 0 | 0 | For |
| State Street | 399,117 | 0 | 0 | 0 | For |
| Hartford | 397,743 | 0 | 0 | 0 | For |
| Allspring | 393,720 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 290,481 | 0 | 0 | 0 | For |
| Brighthouse | 284,890 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 275,060 | 0 | 0 | 0 | For |
| John Hancock | 234,550 | 0 | 0 | 0 | For |
| Equitable | 205,349 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 197,612 | 0 | 0 | 0 | For |
| HEARTLAND GROUP INC | 180,000 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 160,731 | 0 | 0 | 0 | For |
| SCHWARTZ INVESTMENT TRUST | 151,000 | 0 | 0 | 0 | For |
Showing the 25 largest of 114 asset managers. All 114 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Prior year: 84.8% for (August 4, 2023 meeting) ▲ 13.7 pts
Description as filed by funds: Election of Directors: Ellen M. Zane
HAEMONETICS CORP.’s own tally for this item (“Elect Director: Ellen M. Zane”): 47,122,780 for, 709,917 withheld, per its Form 8-K filed July 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 114 asset managers below reported 31,289,999 for, 102,252 withheld, 4,428 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,196,351 | 0 | 0 | 0 | For |
| Capital Group | 3,681,875 | 0 | 0 | 0 | For |
| BlackRock | 3,247,069 | 0 | 0 | 0 | For |
| AMCAP FUND | 3,053,480 | 0 | 0 | 0 | For |
| Neuberger Berman | 2,265,105 | 0 | 0 | 0 | For |
| Fidelity | 1,277,981 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,206,185 | 0 | 0 | 0 | For |
| Royce | 1,017,845 | 0 | 0 | 0 | For |
| Thrivent | 808,322 | 0 | 0 | 0 | For |
| Dimensional | 763,345 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 737,264 | 0 | 0 | 0 | For |
| Charles Schwab | 542,230 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 485,600 | 0 | 0 | 0 | For |
| State Street | 399,117 | 0 | 0 | 0 | For |
| Hartford | 397,743 | 0 | 0 | 0 | For |
| Allspring | 393,720 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 290,481 | 0 | 0 | 0 | For |
| Brighthouse | 284,890 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 275,060 | 0 | 0 | 0 | For |
| John Hancock | 234,550 | 0 | 0 | 0 | For |
| Equitable | 205,349 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 197,612 | 0 | 0 | 0 | For |
| HEARTLAND GROUP INC | 180,000 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 160,731 | 0 | 0 | 0 | For |
| SCHWARTZ INVESTMENT TRUST | 151,000 | 0 | 0 | 0 | For |
Showing the 25 largest of 114 asset managers. All 114 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Prior year: 90.1% for (August 4, 2023 meeting) ▲ 8.7 pts
Description as filed by funds: Election of Directors: Lloyd E. Johnson
HAEMONETICS CORP.’s own tally for this item (“Elect Director: Lloyd E. Johnson”): 47,243,880 for, 588,817 withheld, per its Form 8-K filed July 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 114 asset managers below reported 31,343,068 for, 49,183 withheld, 4,428 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,196,351 | 0 | 0 | 0 | For |
| Capital Group | 3,681,875 | 0 | 0 | 0 | For |
| BlackRock | 3,247,069 | 0 | 0 | 0 | For |
| AMCAP FUND | 3,053,480 | 0 | 0 | 0 | For |
| Neuberger Berman | 2,265,105 | 0 | 0 | 0 | For |
| Fidelity | 1,277,981 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,206,185 | 0 | 0 | 0 | For |
| Royce | 1,017,845 | 0 | 0 | 0 | For |
| Thrivent | 808,322 | 0 | 0 | 0 | For |
| Dimensional | 763,345 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 737,264 | 0 | 0 | 0 | For |
| Charles Schwab | 542,230 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 485,600 | 0 | 0 | 0 | For |
| State Street | 399,117 | 0 | 0 | 0 | For |
| Hartford | 397,743 | 0 | 0 | 0 | For |
| Allspring | 393,720 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 290,481 | 0 | 0 | 0 | For |
| Brighthouse | 284,890 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 275,060 | 0 | 0 | 0 | For |
| John Hancock | 234,550 | 0 | 0 | 0 | For |
| Equitable | 205,349 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 197,612 | 0 | 0 | 0 | For |
| HEARTLAND GROUP INC | 180,000 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 160,731 | 0 | 0 | 0 | For |
| SCHWARTZ INVESTMENT TRUST | 151,000 | 0 | 0 | 0 | For |
Showing the 25 largest of 114 asset managers. All 114 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Prior year: 98.6% for (August 4, 2023 meeting) ▼ 0.5 pts
Description as filed by funds: Election of Directors: Mark W. Kroll
HAEMONETICS CORP.’s own tally for this item (“Elect Director: Mark W. Kroll”): 46,938,807 for, 893,890 withheld, per its Form 8-K filed July 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 114 asset managers below reported 31,284,357 for, 112,322 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,196,351 | 0 | 0 | 0 | For |
| Capital Group | 3,681,875 | 0 | 0 | 0 | For |
| BlackRock | 3,247,069 | 0 | 0 | 0 | For |
| AMCAP FUND | 3,053,480 | 0 | 0 | 0 | For |
| Neuberger Berman | 2,265,105 | 0 | 0 | 0 | For |
| Fidelity | 1,277,981 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,206,185 | 0 | 0 | 0 | For |
| Royce | 1,017,845 | 0 | 0 | 0 | For |
| Thrivent | 808,322 | 0 | 0 | 0 | For |
| Dimensional | 763,345 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 737,264 | 0 | 0 | 0 | For |
| Charles Schwab | 542,230 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 485,600 | 0 | 0 | 0 | For |
| State Street | 399,117 | 0 | 0 | 0 | For |
| Hartford | 397,743 | 0 | 0 | 0 | For |
| Allspring | 393,720 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 290,481 | 0 | 0 | 0 | For |
| Brighthouse | 284,890 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 275,060 | 0 | 0 | 0 | For |
| John Hancock | 234,550 | 0 | 0 | 0 | For |
| Equitable | 205,349 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 130,753 | 0 | 0 | 66,859 | Mixed |
| HEARTLAND GROUP INC | 180,000 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 160,731 | 0 | 0 | 0 | For |
| SCHWARTZ INVESTMENT TRUST | 151,000 | 0 | 0 | 0 | For |
Showing the 25 largest of 114 asset managers. All 114 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.3% Majority: yes · of votes cast
Prior year: 99.3% for (August 4, 2023 meeting) unchanged
Description as filed by funds: Election of Directors: Michael J. Coyle
HAEMONETICS CORP.’s own tally for this item (“Elect Director: Michael J. Coyle”): 47,492,931 for, 339,766 withheld, per its Form 8-K filed July 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 99.3% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 114 asset managers below reported 31,379,759 for, 16,920 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,196,351 | 0 | 0 | 0 | For |
| Capital Group | 3,681,875 | 0 | 0 | 0 | For |
| BlackRock | 3,247,069 | 0 | 0 | 0 | For |
| AMCAP FUND | 3,053,480 | 0 | 0 | 0 | For |
| Neuberger Berman | 2,265,105 | 0 | 0 | 0 | For |
| Fidelity | 1,277,981 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,206,185 | 0 | 0 | 0 | For |
| Royce | 1,017,845 | 0 | 0 | 0 | For |
| Thrivent | 808,322 | 0 | 0 | 0 | For |
| Dimensional | 763,345 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 737,264 | 0 | 0 | 0 | For |
| Charles Schwab | 542,230 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 485,600 | 0 | 0 | 0 | For |
| State Street | 399,117 | 0 | 0 | 0 | For |
| Hartford | 397,743 | 0 | 0 | 0 | For |
| Allspring | 393,720 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 290,481 | 0 | 0 | 0 | For |
| Brighthouse | 284,890 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 275,060 | 0 | 0 | 0 | For |
| John Hancock | 234,550 | 0 | 0 | 0 | For |
| Equitable | 205,349 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 197,612 | 0 | 0 | 0 | For |
| HEARTLAND GROUP INC | 180,000 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 160,731 | 0 | 0 | 0 | For |
| SCHWARTZ INVESTMENT TRUST | 151,000 | 0 | 0 | 0 | For |
Showing the 25 largest of 114 asset managers. All 114 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Prior year: 96.4% for (August 4, 2023 meeting) ▲ 2.3 pts
Description as filed by funds: Election of Directors: Robert E. Abernathy
HAEMONETICS CORP.’s own tally for this item (“Elect Director: Robert E. Abernathy”): 47,233,098 for, 599,599 withheld, per its Form 8-K filed July 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 114 asset managers below reported 31,317,164 for, 75,087 withheld, 4,428 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,196,351 | 0 | 0 | 0 | For |
| Capital Group | 3,681,875 | 0 | 0 | 0 | For |
| BlackRock | 3,247,069 | 0 | 0 | 0 | For |
| AMCAP FUND | 3,053,480 | 0 | 0 | 0 | For |
| Neuberger Berman | 2,265,105 | 0 | 0 | 0 | For |
| Fidelity | 1,277,981 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,206,185 | 0 | 0 | 0 | For |
| Royce | 1,017,845 | 0 | 0 | 0 | For |
| Thrivent | 808,322 | 0 | 0 | 0 | For |
| Dimensional | 763,345 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 737,264 | 0 | 0 | 0 | For |
| Charles Schwab | 542,230 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 485,600 | 0 | 0 | 0 | For |
| State Street | 399,117 | 0 | 0 | 0 | For |
| Hartford | 397,743 | 0 | 0 | 0 | For |
| Allspring | 393,720 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 290,481 | 0 | 0 | 0 | For |
| Brighthouse | 284,890 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 275,060 | 0 | 0 | 0 | For |
| John Hancock | 234,550 | 0 | 0 | 0 | For |
| Equitable | 205,349 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 197,612 | 0 | 0 | 0 | For |
| HEARTLAND GROUP INC | 180,000 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 160,731 | 0 | 0 | 0 | For |
| SCHWARTZ INVESTMENT TRUST | 151,000 | 0 | 0 | 0 | For |
Showing the 25 largest of 114 asset managers. All 114 are in the interactive database (link above).
Combines 8 wordings of this item as funds reported it.
97% Approved · of votes cast
Prior year: 96.2% for (August 4, 2023 meeting) ▲ 0.7 pts
Description as filed by funds: To approve, on an advisory basis, the compensation of our named executive officers.
HAEMONETICS CORP.’s own tally for this item (“2. The compensation of the Company's named executive officers based upon the following votes”): 46,230,466 for, 1,460,004 against — passed, per its Form 8-K filed July 25, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The shareholders approved, on an advisory basis, the compensation of the Company's named executive officers based upon the following votes:”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,196,351 | 0 | 0 | 0 | For |
| Capital Group | 3,681,875 | 0 | 0 | 0 | For |
| BlackRock | 3,247,069 | 0 | 0 | 0 | For |
| AMCAP FUND | 3,053,480 | 0 | 0 | 0 | For |
| Neuberger Berman | 2,265,105 | 0 | 0 | 0 | For |
| Fidelity | 1,277,981 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,206,185 | 0 | 0 | 0 | For |
| Royce | 1,017,845 | 0 | 0 | 0 | For |
| Thrivent | 808,322 | 0 | 0 | 0 | For |
| Dimensional | 763,345 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 737,264 | 0 | 0 | 0 | For |
| Charles Schwab | 542,230 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 485,600 | 0 | 0 | 0 | For |
| State Street | 399,117 | 0 | 0 | 0 | For |
| Hartford | 397,743 | 0 | 0 | 0 | For |
| Allspring | 393,720 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 290,481 | 0 | 0 | 0 | For |
| Brighthouse | 284,890 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 275,060 | 0 | 0 | 0 | For |
| John Hancock | 234,550 | 0 | 0 | 0 | For |
| Equitable | 205,349 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 197,612 | 0 | 0 | 0 | For |
| HEARTLAND GROUP INC | 180,000 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 160,731 | 0 | 0 | 0 | For |
| SCHWARTZ INVESTMENT TRUST | 151,000 | 0 | 0 | 0 | For |
Fund voting reports, all 113 managers: 31,230,151 for, 148,002 against, 16,920 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Research Global Investors | 6,784,216 | 0 | 0 | 0 | For |
| Neuberger Berman | 3,712,042 | 0 | 0 | 0 | For |
| Wellington | 3,086,572 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,105,208 | 0 | 0 | 0 | For |
| State Street | 1,680,593 | 52 | 0 | 0 | For |
| BlackRock | 1,578,887 | 6,441 | 0 | 0 | For |
| FRANKLIN ADVISERS INC | 1,271,175 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,137,440 | 0 | 0 | 0 | For |
| Thrivent | 813,550 | 0 | 0 | 0 | For |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 733,017 | 0 | 0 | 0 | For |
| Northern Trust | 574,700 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 551,274 | 0 | 0 | 0 | For |
| Charles Schwab | 545,450 | 0 | 0 | 0 | For |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 505,649 | 9,258 | 0 | 0 | For |
| Allspring | 487,148 | 0 | 0 | 0 | For |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 456,975 | 13,087 | 0 | 0 | For |
| Boston Trust Walden Co | 306,966 | 0 | 0 | 0 | For |
| LONDON CO OF VIRGINIA | 284,882 | 0 | 0 | 0 | For |
| Aristotle Capital Boston, LLC | 271,571 | 0 | 0 | 0 | For |
| Fisher Asset Management, LLC | 236,806 | 21,684 | 0 | 0 | Mixed |
| Victory Capital | 235,843 | 0 | 0 | 0 | For |
| Hood River Capital Management LLC | 229,159 | 0 | 0 | 0 | For |
| PRINCIPAL GLOBAL INVESTORS | 208,021 | 0 | 0 | 0 | For |
| Fidelity | 195,949 | 0 | 0 | 0 | For |
| HEARTLAND ADVISORS INC | 188,331 | 0 | 0 | 0 | For |
Institutional-manager reports, all 264 managers: 31,750,527 for, 825,588 against, 104,478 abstained, 1,693 not voted. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
98% Approved · of votes cast
Prior year: 98.5% for (August 4, 2023 meeting) ▼ 0.6 pts
Description as filed by funds: To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending March 29, 2025.
HAEMONETICS CORP.’s own tally for this item (“3. The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending March 30, 2024 based upon the following votes”): 47,738,769 for, 1,049,682 against — passed, per its Form 8-K filed July 25, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The shareholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending March 30, 2024 based upon the following votes:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 114 asset managers below reported 31,348,268 for, 28,543 against, 16,920 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,196,351 | 0 | 0 | 0 | For |
| Capital Group | 3,681,875 | 0 | 0 | 0 | For |
| BlackRock | 3,247,069 | 0 | 0 | 0 | For |
| AMCAP FUND | 3,053,480 | 0 | 0 | 0 | For |
| Neuberger Berman | 2,265,105 | 0 | 0 | 0 | For |
| Fidelity | 1,277,981 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,206,185 | 0 | 0 | 0 | For |
| Royce | 1,017,845 | 0 | 0 | 0 | For |
| Thrivent | 808,322 | 0 | 0 | 0 | For |
| Dimensional | 763,345 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 737,264 | 0 | 0 | 0 | For |
| Charles Schwab | 542,230 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 485,600 | 0 | 0 | 0 | For |
| State Street | 399,117 | 0 | 0 | 0 | For |
| Hartford | 397,743 | 0 | 0 | 0 | For |
| Allspring | 393,720 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 290,481 | 0 | 0 | 0 | For |
| Brighthouse | 284,890 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 275,060 | 0 | 0 | 0 | For |
| John Hancock | 234,550 | 0 | 0 | 0 | For |
| Equitable | 205,349 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 197,612 | 0 | 0 | 0 | For |
| HEARTLAND GROUP INC | 180,000 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 160,731 | 0 | 0 | 0 | For |
| SCHWARTZ INVESTMENT TRUST | 151,000 | 0 | 0 | 0 | For |
Showing the 25 largest of 114 asset managers. All 114 are in the interactive database (link above).
Not shown here: this season’s fund filings also report 11 items from the meeting of July 24, 2025, which belongs to the 2025-2026 season. A meeting outside this season’s July 1 to June 30 window is not counted in this page’s items or in its totals of asset managers and fund votes.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 51,152,886 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 12.11% |
| 2 | Capital Group | 7.20% |
| 3 | BlackRock | 6.35% |
| 4 | AMCAP FUND | 5.97% |
| 5 | Neuberger Berman | 4.43% |
| 6 | Fidelity | 2.50% |
| 7 | T. Rowe Price | 2.36% |
| 8 | Royce | 1.99% |
| 9 | Thrivent | 1.58% |
| 10 | Dimensional | 1.49% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Capital Research Global Investors | 13.26% |
| 2 | Neuberger Berman | 7.26% |
| 3 | Wellington | 6.03% |
| 4 | T. Rowe Price | 4.12% |
| 5 | State Street | 3.29% |
| 6 | BlackRock | 3.10% |
| 7 | FRANKLIN ADVISERS INC | 2.49% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 2.22% |
| 9 | Thrivent | 1.59% |
| 10 | SCHRODER INVESTMENT MANAGEMENT GROUP | 1.43% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| BlackRock | 6,357,164 | 12.43% | Form 13F, quarter ended March 31, 2025 |
| Vanguard Group | 5,099,621 | 9.97% | Form 13F, quarter ended March 31, 2025 |
| Neuberger Berman Group LLC | 3,531,181 | 6.90% | Proxy statement (DEF 14A), proxy filed June 6, 2025 |
| AQR Capital Management, LLC | 3,163,104 | 6.18% | Schedule 13G, filed February 13, 2026 |
| Vanguard Portfolio Management | 2,600,145 | 5.08% | Schedule 13G, filed April 29, 2026 |
| Wellington Management Group LLP | 2,203,351 | 4.31% | Schedule 13G, filed August 12, 2025 |
| T. Rowe Price Investment Management, Inc. | 2,195,569 | 4.29% | Schedule 13G, filed May 14, 2025 |
| State Street | 1,918,016 | 3.75% | Form 13F, quarter ended March 31, 2025 |
| Geode Capital | 1,221,367 | 2.39% | Form 13F, quarter ended March 31, 2025 |
| Dimensional Fund Advisors | 1,063,702 | 2.08% | Form 13F, quarter ended March 31, 2025 |
Percentages above are of 51,152,886 shares outstanding, as reported by HAEMONETICS CORP. on its Form 10-Q dated June 29, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At HAEMONETICS CORP.'s shareholder meeting held July 25, 2024, in the 2024-2025 proxy season, 352 asset managers reported votes on at least one of its 11 ballot items in their SEC Form N-PX filings, covering 4,885 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of our named executive officers. — HAEMONETICS CORP.'s filing reports the proposal as approved, with 97% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: HAEMONETICS CORP.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on July 25, 2024.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from HAEMONETICS CORP.’s 10-Q dated June 29, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
HAEMONETICS CORP. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
Proxy Votes Now, “HAEMONETICS (HAE) 2024 Annual Meeting (2024-2025 season): Vote Results”, https://proxyvotesnow.com/company/haemonetics-corp/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.